Erfolgreich hinzugefügt!
Kursdaten 
Chart
News + Analysen
Fundamental
Unternehmen
Derivate
Aktion
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 100,00 |
| Massachusetts Financial Services Co. | 4,91 |
| Templeton Global Advisors Ltd. | 3,01 |
| Government Pension Fund - Global (the) | 1,98 |
| Vanguard Total International Stock Index Fund | 1,61 |
| American Funds Europacific Growth Fund | 1,30 |
| Templeton Growth Fund Inc. | 0,86 |
| Mfs Institutional International Equity Fund | 0,81 |
| Dws Aktien Strategie Deutschland | 0,70 |
| Dws Deutschland | 0,69 |
| Invesco Funds - Pan European Structured Equity Fund | 0,67 |
| Vanguard Developed Markets Index Fund | 0,62 |
| Ishares Dax (de) | 0,62 |
| Ftif Sicav - Growth (euro) Fund | 0,57 |
| Ivy Funds - International Core Equity Fund | 0,54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 49.613 | 50.414 | 52.880 | 51.713 | 57.036 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,26 | 0,30 | 0,29 | 0,29 | 0,28 |
Bilanz (in Mio. EUR) - Aktiva
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 7.348 | 7.666 | 7.447 | 9.236 | 9.003 |
| Summe Anlagevermögen | 26.290 | 26.438 | 23.946 | 25.183 | 31.059 |
| Summe Aktiva | 38.787 | 39.002 | 36.063 | 37.403 | 44.201 |
Bilanz (in Mio. EUR) - Passiva
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 13.503 | 12.449 | 9.943 | 7.983 | 13.194 |
| Summe Fremdkapital | 25.931 | 24.952 | 21.997 | 20.170 | 26.288 |
| Summe Eigenkapital | 12.855 | 14.050 | 14.066 | 17.233 | 17.913 |
| Summe Passiva | 38.787 | 39.002 | 36.063 | 37.403 | 44.201 |
Adresse
| Frankfurter Strasse 250, 64293 Darmstadt | |
| Telefon | +49 (6151) 72-9880 |
| Fax | +49 (6151) 72-5962 |
| Internet | http://www.merck.de |
Management
|
Anand Nambiar
Global Head-Semiconductor Solutions |
|
Anne Lange
Member-Supervisory Board |
|
Belén Garijo López
Chief Executive Officer-Healthcare |
|
Christian Raabe
Member-Supervisory Board |
|
Constantin Fest
Head-Investor Relations |
|
Daniel Thelen
Member-Supervisory Board |
|
Dietmar Eidens
Head-Human Resources |
|
Dietmar Oeter
Member-Supervisory Board |
|
Dorothea Wenzel
Head-Controlling & Strategy |
|
Edeltraud Glänzer
Member-Supervisory Board |
|
Friederike Rotsch
Group General Counsel, Head-Legal & Compliance |
|
Gabriele Eismann
Member-Supervisory Board |
|
Heidi Fagerholm
Head-Advanced Technologies |
|
Helene von Roeder
Member-Supervisory Board |
|
Helga Rübsamen-Schaeff
Member-Supervisory Board |
|
Jürgen Glaser
Member-Supervisory Board |
|
Kai Beckmann
Chief Executive Officer-Performance Materials |
|
Marcus Kuhnert
Chief Financial Officer |
|
Maya Martinez-Davis
President-Biopharma Latin America |
|
Michael Fletterich
Vice Chairman-Supervisory Board |
|
Michael Heckmeier
EVP & Head-Business Unit Display Materials |
|
Michael Kleinemeier
Member-Supervisory Board |
|
Peter Emanuel Merck
Member-Supervisory Board |
|
Renate Koehler
Member-Supervisory Board |
|
Sascha Held
Member-Supervisory Board |
|
Simon Thelen
Member-Supervisory Board |
|
Stefan Oschmann
Chairman-Executive Board & CEO |
|
Udit Batra
Chief Executive Officer-Life Science |
|
Walter Galinat
Member-Executive Board |
|
Wolfgang Heinz Büchele
Chairman-Supervisory Board |
